Enhanced antitumor activity of combined megestrol acetate and arsenic trioxide treatment in liver cancer cells-Reference-Cited by-同舟云学术

Enhanced antitumor activity of combined megestrol acetate and arsenic trioxide treatment in liver cancer cells

Published:2018-02-28 Issue: Volume: Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Xia Yan¹,Liu Xianhao²,Liu Beibei²,Zhang Xiaoshi¹,Tian Geng²

Affiliation:

1. Department of Biotherapy Research Center, Sun Yat‑sen University Cancer Center, Guangzhou, Guangdong 510060, P.R. China

2. Department of Oncology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518035, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma;Cell Death & Disease;2024-04-29

2. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach;EPMA Journal;2023-08-10

3. Thiolated chitosan nanoparticles for stable delivery and smart release of As2O3 for liver cancer through dual actions;Carbohydrate Polymers;2023-03

4. A combined arsenic trioxide/tetrandrine nanoparticle formulation with improved inhibitory effect against promyelocytic leukemia;Journal of Drug Delivery Science and Technology;2022-08

5. Long-circulating doxorubicin and schizandrin A liposome with drug-resistant liver cancer activity: preparation, characterization, and pharmacokinetic;Journal of Liposome Research;2021-09-13